Author: Walley Matthew Hotz-Behofsits Christoph Simpson Robert Bjarnason Ingvar
Publisher: VSP
ISSN: 1568-5608
Source: Inflammopharmacology, Vol.11, Iss.4-6, 2003-12, pp. : 429-436
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Role of Nitric Oxide in Neurodegeneration: Potential for Pharmacological Intervention
By Molina J.A.
Drugs & Aging, Vol. 12, Iss. 4, 1998-04 ,pp. :
NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor
By Ellis James L. Augustyniak Michael E. Cochran Edward D. Earl Richard A. Garvey David S. Gordon Laura J. Janero David R. Khanapure Subhash P. Letts L. Gordon Melim Terry L. Murty Madhavi G. Schwalb David J. Shumway Matthew J. Selig William M. Trocha A. Mark Young Delano V. Zemtseva Irina S.
Inflammopharmacology, Vol. 12, Iss. 5-6, 2004-12 ,pp. :
The potential of nitric oxide therapeutics in stroke
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. :
Nitric oxide and its role in apoptosis
By Brune B. von Knethen A. Sandau K.B.
European Journal of Pharmacology, Vol. 351, Iss. 3, 1998-06 ,pp. :